Venetoclax and hypomethylating agents in acute myeloid leukemia: Mayo Clinic series on 86 patientsErika Morsia, Naseema Gangat, Hassan B. Alkhateeb et al.|American Journal of Hematology|2020Cited by 136
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohortMithun Vinod Shah, Devendra Hiwase, Kevin Hung et al.|Blood Cancer Journal|2025Cited by 6